| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Eric Risser
Also a director
President, Chief Executive Officer and Director
|
53 | Not stated | 2009 | $2,078,854 | |
|
James Karrels
Senior Vice President and Chief Financial Officer
|
59 | Not stated | 2008 | $1,149,232 | |
|
Jeffrey Peters
Senior Vice President, General Counsel, Corporate Compliance Officer and Corporate Secretary
|
55 | Not stated | 2015 | Not reported | |
|
Ezio Bonvini
Sr VP, Research & CSO
Title from the Form 4 dated Oct 6, 2026
|
72 | Not stated | 2003 | $1,224,038 | |
|
Thomas Spitznagel
Senior Vice President, Technical Operations
|
59 | Not stated | 2013 | Not reported | |
|
Beth Smith
Vice President, Controller and Treasurer
|
58 |
Since 2024
2 years
|
2013 | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 8, 2026 · updated by the 8-Ks of Jul 8, 2026 and Nov 3, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
William Heiden
Board chair
|
66 | Not stated | Not stated | None stated | Atara Biotherapeutics, Inc. | $145,030 | |
|
Eric Risser
CEO
|
53 | Not stated | Not independent | None stated | None stated | Paid as CEO | |
|
Scott Koenig
|
73 |
2001
25 years
|
Not independent | None stated | None stated | Not stated | |
|
Federica O'Brien
|
68 |
2021
5 years
|
Not stated | None stated | TELA Bio, Inc. | $110,477 | |
|
Scott Jackson
|
61 |
2017
9 years
|
Not stated | None stated | Spero Therapeutics, Inc. | $81,905 | |
|
Margaret A. Liu
|
69 |
2023
3 years
|
Not stated | None stated | Ipsen | $85,863 | |
|
David Stump
|
76 |
2013
13 years
|
Not stated | None stated | REGENXBIO, Inc. | $95,863 | |
|
Edward Hurwitz
|
62 |
2004
22 years
|
Not stated | None stated | Dyne Therapeutics | $85,863 | |
|
Meenu Chhabra Karson
|
53 |
2023
3 years
|
Not stated | None stated | None stated | $80,217 | |
|
Michael Vasconcelles
Joined Oct 30, 2026
|
- | - | Independent |
Science and Technology Committee
|
- | - | |
|
Emil Kuriakose
Joined Oct 30, 2026
|
- | - | Independent |
Science and Technology Committee
|
- | - | |
|
Jay Siegel
Leaving at the meeting
|
73 |
2017
9 years
|
Not stated | None stated | None stated | $106,280 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 8, 2026 states there were none.
Read it in the proxyLoading...